Comparative study of the effects of some inducers with or without protein binding properties on bioavailability of isoxazolylpenicillins in rats

  • M. Couvaris
  • P. Galanopoulou
  • Ch. Karageorgiou
  • S. Theodosopoulos
  • D. Varonos
Original Papers


The effect of various inducers with or without protein binding properties on serum levels and half life of Oxacillin, Cloxacillin and Dicloxacillin was studied. A total of 102 male rats classified in 3 “categories” according to the administered penicillin with 6 groups of rats in each of them were used. Each group was pretreated for 15 days with the following inducers: phenobarbital, diphenylhydantoin, diazepam, chlorpromazine and phenylbutazone. The control groups received saline. The d-glucaric acid concentration in the urine prior to and after the administration of inducers and the liver weight were taken as enzyme induction indices.

The results showed a decrease of serum levels and half life of three penicillins with a negative correlation between urine d-glucaric acid and serum penicillin levels.

Phenobarbital, diphenylhydantoin and chlorpromazine affected the 3 penicillins in the following statistically significant order: oxacillin, dicloxacillin, cloxacillin. Diazepam affected: cloxacillin, dicloxacillin, oxacillin, and phenylbutazone: dicloxacillin, cloxacillin and oxacillin.

However all drugs finally produced a uniform effect on all 3 penicillins in the following decreasing order: Phenobarbital (r = − 0.910), diphenylhydantoin (r = −0.864), phenylbutazone (r = −0.851), chlorpromazine (r = − 0.842) and diazepam (r = −0.821). For all inducers, the effect was most significant for oxacillin (r = −0.869), second most significant for dicloxacillin (r = −0.811) and finally for cloxacillin (r 0.778).

The results suggested an interaction of isoxazolylpenicillins and the above drugs.


Enzyme induction Protein binding Bioavailability Isoxazolylpenicillins Oxacillin Cloxacillin Dicloxacillin Phenobarbital Diphenylhydantoin Chlorpromazine Diazepam Phenylbutazone 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Conney A.H. (1967): Pharmacological implications of microsomal enzyme induction. Pharmacological Reviews,19, 317–366.PubMedGoogle Scholar
  2. 2.
    Marshall W.J. (1978): Enzyme induction by drugs. Its relevance to clinical biochemistry. Annals of Clinical Biochemistry,15, 55–64.PubMedGoogle Scholar
  3. 3.
    Busfield D., Child K.J. and Tomich E.G. (1964): An effect of phenobarbitone on griseofulvin metabolism in the rat. British Journal of Pharmacology and Chemotherapy,22, 137–142.PubMedGoogle Scholar
  4. 4.
    Neuvonen P.J. and Penttila O. (1974): Interaction between Doxycycline and Barbiturates. British Medical Journal,7, 535–536.CrossRefGoogle Scholar
  5. 5.
    Pentilla O., Neuvonen P.J., Aho K. and Lehtovaara (1974): Interaction between Doxycycline and some antiepileptic drugs. British Medical Journal,2, 470–472.CrossRefGoogle Scholar
  6. 6.
    Schwartz G.J., Hegyi T. and Spitzer A. (1976): Subtherapeutic dicloxacillin levels in a neonate: possible mechanisms. The Journal of Pediatrics,89, 310–312.CrossRefPubMedGoogle Scholar
  7. 7.
    Galanopoulou P., Karageorgiou Ch., Couvaris M. and Varonos D. (1980): Influence on liver enzyme induction caused by Phenobarbital in the biotransformation of hetacillin in male rats. Journal of Antimicrobial Chemotherapy. (Corrspondence),6, 157–159.CrossRefGoogle Scholar
  8. 8.
    Couvaris M., Galanopoulou P., Karageorgiou Ch., Abdel Jalil H. and Varonos D. (1985): Bioavailability of hetacillin in rats after liver enzyme induction by various inducers with or without protein binding properties. European Journal of Drug Metabolism and Pharmacokinetics,10(1), 27–32.PubMedGoogle Scholar
  9. 9.
    Rolinson G.N. and Batchelor F.R. (1963): Penicillin metabolites. Antimicrobial Agents and Chemotherapy,1962, 654–660.Google Scholar
  10. 10.
    Thijssen H.H.W. and Mattie H. (1976): Active Metabolites of Isoxazolpenicillins in humans. Antimicrobial Agents and Chemotherapy,10, 441–446.PubMedGoogle Scholar
  11. 11.
    Thijssen H.H.W. (1979): Identification of the active metabolites of the Isoxazolylpenicillins by means of mass-spectrometry. The Journal of Antibiotics,32, 1033–1037.PubMedGoogle Scholar
  12. 12.
    Vainio H. (1976): Linkage of microsomal drug oxidation and glucuronidation. In Proceedings of the 6th International Congress of Pharmacology. (General editors J. Tuomis and M.K. Paasonen). Vol. 6, “Mechanisms of toxicity and metabolism” (N.J. Karki e.d.). Pergamon Press Oxford — New York, Sydney.Google Scholar
  13. 13.
    Sotaniemi E.A., Madzihradsky F. and Elliason G. (1974): D-Glucaric acid as an indicator of use of enzyme inducing drugs. Clinical Pharmacology and Therapeutics,15, 417–423.PubMedGoogle Scholar
  14. 14.
    Silvestrini B., Catanese B. and Del-Basso P. (1966): Researches on the increase of liver weight produced by some drugs. Biochemical Pharmacology,15, 249–254.CrossRefPubMedGoogle Scholar
  15. 15.
    Bennet J.V., Brodie J.L., Benner E.J. and Kirby W.M. (1966): Simplified accurate method for antibiotic assay of clinical Specimens. Applied Microbiology,14, 170–177.Google Scholar
  16. 16.
    Marsh C.A. (1963): Metabolism of D-Glucuronolactone in mamalian systems. Identification of D-glucaric acid as a normal constituent of urine. Journal Biochemistry, 86, 77–86.Google Scholar
  17. 17.
    Downie N.M. and Heath R.W. (1976): “Basic Statistical Methods” 4th ed. by Harper and Row Publishers.Google Scholar
  18. 18.
    Rosenblatt J.E., Kind A.C., Brodie J.L. and Kirby W.M.M. (1968): Mechanisms responsible for the blood level differences of isoxazolylpenicillins, oxacillin, cloxacillin and dicloxacillin. Archives International Medicine,121, 345–348.CrossRefGoogle Scholar
  19. 19.
    Marselos M. (1976): Genetic variation of drug-metabolizing enzymes in the wistar rat. Acta Pharmacologica and Toxicologica,39, 186.Google Scholar
  20. 20.
    Goodman L.S. and Gilmann A. (1975): “The Pharmacological Basis of Therapeutics”, 5th edition, Macmillan publishing Co., Inc. New York, p. 340.Google Scholar
  21. 21.
    Sutherland R., Croydon E.A.P. and Rolinson G.N. (1970): Flucloxacillin, a new isoxazolylpenicillin compared with oxacillin, cloxacillin and dicloxacillin. British Medical Journal,4, 455–460.CrossRefPubMedGoogle Scholar
  22. 22.
    Rolinson G.N. and Sutherland R. (1973): Semisynthetic penicillins. Adv. Pharmacology and Chemotherapy,11, 151–220.CrossRefGoogle Scholar
  23. 23.
    Biagi G.I., Barbaro A.M., Gamba M.F. and Guerra M.C. (1969): Partition data of penicillins determined by means of reverked phase thin-layer chromatography. Journal of Chromatography,41, 371–379.PubMedGoogle Scholar
  24. 24.
    Cole M., Kenig M.D. and Hewitt V.A. (1973): Metabolism of Penicillins to Penicilloic Acids and 6-Amnopenicillanic Acid in Man and its Significance in Assessing Penicillin absorption. Antimicrobial Agents and Chemotherapy,3 (4), 463–468.PubMedGoogle Scholar

Copyright information

© Springer-Verlag 1986

Authors and Affiliations

  • M. Couvaris
    • 1
  • P. Galanopoulou
    • 1
  • Ch. Karageorgiou
    • 1
  • S. Theodosopoulos
    • 1
  • D. Varonos
    • 1
  1. 1.Department of Experimental Pharmacology, Medical SchoolAthens UniversityAthensGreece

Personalised recommendations